Studies have demonstrated that the elevated expression of GPX4, a core ferroptosis regulator, is associated with high-grade thyroid cancer [85], and another key regulator, SLC7A11, is linked to poor prognosis [86]. This evidence concerns the gene GPX4 and thyroid gland carcinoma.